Jane Street
PROF

Jane Street’s Profound Medical PROF Stock Holding History

Jane Street’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$272K Buy
+42,000
New +$290K ﹤0.01% 9439

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Jane Street's PROF Position: Q1 2026 in Review

Jane Street opened a new position in Profound Medical (PROF) in Q1 2026: 36,687 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #9741 among its holdings. This is a return to the name: Jane Street previously reported a position in PROF as recently as Q1 2023.

Jane Street first reported a position in PROF in Q1 2022 and has held it in 3 quarters since. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Jane Street held 36,687 shares of Profound Medical worth $238K as of Q1 2026.
  • Profound Medical was a new Jane Street position in Q1 2026.
  • Profound Medical made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9741 holding.
  • Jane Street first reported a position in Profound Medical in Q1 2022 and has held it in 3 quarters since.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.